Categories: Market Research

Global Pharmaceutical Intermediates Market Size and Forecast 2024-2033|BASF SE, Sanofi SA, Thermo Fisher Scientific Inc., Meck KGaA, Dishman Carbogen Amcis Ltd

The Pharmaceutical Intermediates Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Pharmaceutical Intermediates Market:

https://www.thebusinessresearchcompany.com/report/pharmaceutical-intermediates-global-market-report

According to The Business Research Company’s Pharmaceutical Intermediates Global Market Report 2024, The pharmaceutical intermediates market size has grown strongly in recent years. It will grow from $31.33 billion in 2023 to $33.59 billion in 2024 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to chemical synthesis advancements, drug development evolution, market demand and growth, research and development, regulatory compliance.

The pharmaceutical intermediates market size is expected to see strong growth in the next few years. It will grow to $43.01 billion in 2028 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to biopharmaceutical innovation, precision medicine development, green chemistry initiatives, customized intermediates, pharmaceutical outsourcing trends. Major trends in the forecast period include continuous flow chemistry, increased automation and robotics, application of nanotechnology, biocatalysis and enzyme engineering, strategic supply chain management.

The rise in the prevalence of chronic diseases is expected to propel the growth of the pharmaceutical intermediates market going forward. Chronic diseases refer to a sickness or condition that typically lasts three months or longer and has the potential to worsen over time. The rise in chronic diseases is mostly driven by the aging population, lifestyle changes, rapid urbanization, and lack of preventive measures, where pharmaceutical intermediates play a crucial role in the development and production of medications used to manage chronic diseases. For instance, in March 2022, according to the National Institute of Health, a US-based medical research agency, the prevalence of chronic kidney disorders will be 13.4%. Additionally, it is projected that between 4.902 and 7.083 million individuals will require renal replacement therapy due to end-stage kidney disease (ESKD). The utilization of accurate pharmaceutical intermediates can play a significant role in mitigating the increasing prevalence of chronic conditions. Therefore, the rise in the prevalence of chronic diseases is driving the growth of the pharmaceutical intermediates market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=11948&type=smp

The pharmaceutical intermediates market covered in this report is segmented –

1) By Product: Chemical Intermediate, Bulk Drug Intermediate, Other Products

2) By Category: Branded Drug Intermediate, Generic Drug Intermediate

3) By Application: Analgesics, Anti-Infective Drugs, Cardiovascular Drugs, Oral Antidiabetic Drugs, Antimicrobial Drugs, Other Applications

4) By End-User: Biotech And Pharma Companies, Research Institutions, Other End-Users

Major companies operating in the pharmaceutical intermediates market are innovating new product lines such as API Intermediates to increase their profitability in the market. API intermediates are chemical compounds that are used in the synthesis of active pharmaceutical ingredients (APIs). For instance, in October 2023, Huateng Pharmaceutical Co. Ltd., a China-based pharmaceutical company launched its exciting product line called Gastrointestinal API Intermediates. These intermediates function as the building blocks for the pharmaceutical active ingredients found in digestive system medications. They are necessary for the production of medications that treat disorders of the gastrointestinal system, including laxatives, 5-HT3 receptor antagonists, H2-receptor antagonists, and proton pump inhibitors.

The pharmaceutical intermediates market report table of contents includes:

1. Executive Summary

2. Pharmaceutical Intermediates Market Characteristics

3. Pharmaceutical Intermediates Market Trends And Strategies

4. Pharmaceutical Intermediates Market – Macro Economic Scenario

5. Global Pharmaceutical Intermediates Market Size and Growth

26. South America Pharmaceutical Intermediates Market

27. Brazil Pharmaceutical Intermediates Market

28. Middle East Pharmaceutical Intermediates Market

29. Africa Pharmaceutical Intermediates Market

30. Pharmaceutical Intermediates Market Competitive Landscape And Company Profiles

Top Major Players: